NISA INVESTMENT ADVISORS, LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$18,587
-12.6%
7510.0%0.00%
Q2 2023$21,268
+193245.5%
751
+54.8%
0.00%
Q1 2023$11
-78.0%
485
-72.8%
0.00%
Q4 2022$50
-99.9%
1,7850.0%0.00%
Q3 2022$49,000
+25.6%
1,785
+2.6%
0.00%
Q2 2022$39,000
+200.0%
1,740
+295.5%
0.00%
Q1 2022$13,000
-75.5%
440
-74.3%
0.00%
Q4 2021$53,000
-59.5%
1,710
-39.6%
0.00%
-100.0%
Q3 2021$131,000
-16.0%
2,8300.0%0.00%0.0%
Q2 2021$156,000
+7.6%
2,830
+1.1%
0.00%0.0%
Q1 2021$145,000
+457.7%
2,800
+366.7%
0.00%
Q4 2020$26,000
-69.8%
600
-75.6%
0.00%
-100.0%
Q3 2020$86,000
+168.8%
2,458
+309.7%
0.00%
Q2 2020$32,000
+52.4%
6000.0%0.00%
Q1 2020$21,000
-90.2%
600
-87.1%
0.00%
-100.0%
Q4 2018$214,000
-40.2%
4,6420.0%0.00%
-33.3%
Q3 2018$358,000
+4375.0%
4,642
+2221.0%
0.00%
Q1 2016$8,0002000.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders